Rochelle D. Schwartz-Bloom
Professor in the Program in Education
Dr. Schwartz-Bloom is a co-principal investigator for the National Science Foundation Phase II Noyce Fellowship program.
The Schwartz-Bloom laboratory has completed 18 years of research investigating novel pharmacologic approaches to prevent neuronal death caused by cerebral ischemia associated with cardiac arrest and stroke. The group studied how GABA neurotransmission dysfunction contributes to the death of hippocampal neurons after ischemia in vivo or in vitro. Dr. Schwartz-Bloom’s research program continues now exclusively in science education, which she started in 1996. With funds provided by the Duke Provost in 2007, Dr. Schwartz-Bloom established Duke Center for Science Education, an umbrella for all Duke-related activities in science education. She coordinates Duke faculty and student interests in curriculum development, research, and outreach activities in science education for the K-16 grades. Dr. Schwartz-Bloom also directs RISE (Raising Interest in Science Education, http://sites.duke.edu/rise), an office within the Department of Pharmacology and Cancer Biology, where she develops and provides novel science education curricular materials in the area of pharmacology to the K-12 and college community. One of the major programs that she developed is the Pharmacology Education Partnership (http://sites.duke.edu/thepepproject), a series of pharmacology- and drug abuse-related science education modules for high school biology and chemistry students. Testing of over 15,000 high school students has revealed that student performance in biology and chemistry improves when they use the pharmacology curriculum developed by her team. Dr. Schwartz-Bloom provides several opportunities for Duke Pharmacology graduate students and post-doctoral fellows to obtain experience in teaching.
- Ph.D., Georgetown University 1983
Schwartz, R. D., et al. “Barbiturate and picrotoxin-sensitive chloride efflux in rat cerebral cortical synaptoneurosomes..” Febs Letters, vol. 175, no. 1, Sept. 1984, pp. 193–96. Epmc, doi:10.1016/0014-5793(84)80597-9. Full Text
Rainbow, T. C., et al. “Quantitative autoradiography of nicotinic [3H]acetylcholine binding sites in rat brain..” Neuroscience Letters, vol. 50, no. 1–3, Sept. 1984, pp. 193–96. Epmc, doi:10.1016/0304-3940(84)90485-3. Full Text
Schwartz, R. D., et al. “Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain..” Journal of Neurochemistry, vol. 42, no. 5, May 1984, pp. 1495–98. Epmc, doi:10.1111/j.1471-4159.1984.tb02818.x. Full Text
Schwartz, R. D., et al. “Muscarinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.” Federation Proceedings, vol. 43, no. 3, Jan. 1984.
Schwartz, R. D., and K. J. Kellar. “[3H]acetylcholine binding sites in brain. Effect of disulfide bond modification..” Molecular Pharmacology, vol. 24, no. 3, Nov. 1983, pp. 387–91.
Schwartz, R. D., and K. J. Kellar. “Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo..” Science (New York, N.Y.), vol. 220, no. 4593, Apr. 1983, pp. 214–16. Epmc, doi:10.1126/science.6828889. Full Text
Schwartz, R. D., and K. J. Kellar. “[3H]Acetylcholine binding sites in brain. Effect of disulfide bond modification.” Molecular Pharmacology, vol. 24, no. 3, 1983, pp. 387–91.
Schwartz, R. D., et al. “Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain..” Molecular Pharmacology, vol. 22, no. 1, July 1982, pp. 56–62.
Schwartz, R. D., et al. “Effects of chronic phencyclidine on fixed-ratio responding: no relation to neurotransmitter receptor binding in rat cerebral cortex..” Pharmacology, Biochemistry, and Behavior, vol. 16, no. 4, Apr. 1982, pp. 647–52. Epmc, doi:10.1016/0091-3057(82)90431-2. Full Text
Autrup, H., et al. “Metabolism of 1,2-dimethylhydrazine by cultured human colon..” Carcinogenesis, vol. 1, no. 5, May 1980, pp. 375–80. Epmc, doi:10.1093/carcin/1.5.375. Full Text